Oriola Oyj — Financial Supplement Data 2026

Mar 20, 2026

Comparative segment information

Invoicing EUR million	2025 1-12	2024 1-12
Services	4,146.0	3,707.1
Products*	66.4	79.6
Invoicing between segments	-11.2	-14.9
Total	4,201.2	3,771.8
*Including dose dispensing Sweden	6.0	21.7
Net sales EUR million	2025 1-12	2024 1-12
Services	150.6	135.1
Products*	65.4	78.2
Net sales between segments	-11.2	-14.9
Total	204.8	198.4
*Including dose dispensing Sweden	5.1	20.0
Adjusted EBITDA EUR million	2025 1-12	2024 1-12
Services	37.3	34.6
Products*	5.7	5.5
Group administration and others	-7.9	-6.7
Total	35.1	33.4
*Including dose dispensing Sweden	0.2	0.1
EBITDA EUR million	2025 1-12	2024 1-12
Services	35.4	34.5
Products*	2.9	6.0
Group administration and others	-18.0	-13.3
Total	20.3	27.2
*Including dose dispensing Sweden	-2.5	1.6
Adjusting items EUR million	2025 1-12	2024 1-12
Services	1.9	0.1
Products*	2.8	-0.5
Group administration and others	10.1	6.7
Total	14.8	6.2
*Including dose dispensing Sweden	2.8	-1.4
Number of personnel at the end of the period	2025 1-12	2024 1-12
Services	487	460
Products*	237	284
Group administration and others	76	72
Total	801	816
*Including dose dispensing Sweden	-	49
Average number of personnel, full time equivalents	2025 1-12	2024 1-12
Services	496	458
Products*	237	280
Group administration and others	80	74
Total	813	812
*Including dose dispensing Sweden	12	48
Non-current assets¹ EUR million	2025 311bpc	2024 311bpc
Services	72.2	61.9
Products	6.6	18.5
Group administration and others	207.4	232.4
Total	286.2	312.8

¹ Non-current assets exclude financial instruments and deferred tax assets.